367 related articles for article (PubMed ID: 36812215)
1. Post COVID-19 condition after Wildtype, Delta, and Omicron SARS-CoV-2 infection and prior vaccination: Pooled analysis of two population-based cohorts.
Ballouz T; Menges D; Kaufmann M; Amati R; Frei A; von Wyl V; Fehr JS; Albanese E; Puhan MA
PLoS One; 2023; 18(2):e0281429. PubMed ID: 36812215
[TBL] [Abstract][Full Text] [Related]
2. Association between SARS-CoV-2 variants and post COVID-19 condition: findings from a longitudinal cohort study in the Belgian adult population.
Thi Khanh HN; Cornelissen L; Castanares-Zapatero D; De Pauw R; Van Cauteren D; Demarest S; Drieskens S; Devleesschauwer B; De Ridder K; Charafeddine R; Smith P
BMC Infect Dis; 2023 Nov; 23(1):774. PubMed ID: 37940843
[TBL] [Abstract][Full Text] [Related]
3. Association between virus variants, vaccination, previous infections, and post-COVID-19 risk.
Diexer S; Klee B; Gottschick C; Xu C; Broda A; Purschke O; Binder M; Frese T; Girndt M; Hoell JI; Moor I; Gekle M; Mikolajczyk R
Int J Infect Dis; 2023 Nov; 136():14-21. PubMed ID: 37634619
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous manifestations of SARS-CoV-2 infection during the Delta and Omicron waves in 348 691 UK users of the UK ZOE COVID Study app.
Visconti A; Murray B; Rossi N; Wolf J; Ourselin S; Spector TD; Freeman EE; Bataille V; Falchi M
Br J Dermatol; 2022 Dec; 187(6):900-908. PubMed ID: 35869671
[TBL] [Abstract][Full Text] [Related]
5. A Quick Displacement of the SARS-CoV-2 variant Delta with Omicron: Unprecedented Spike in COVID-19 Cases Associated with Fewer Admissions and Comparable Upper Respiratory Viral Loads.
Fall A; Eldesouki RE; Sachithanandham J; Morris CP; Norton JM; Gaston DC; Forman M; Abdullah O; Gallagher N; Li M; Swanson NJ; Pekosz A; Klein EY; Mostafa HH
medRxiv; 2022 Jan; ():. PubMed ID: 35118480
[TBL] [Abstract][Full Text] [Related]
6. Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study.
Babouee Flury B; Güsewell S; Egger T; Leal O; Brucher A; Lemmenmeier E; Meier Kleeb D; Möller JC; Rieder P; Rütti M; Schmid HR; Stocker R; Vuichard-Gysin D; Wiggli B; Besold U; McGeer A; Risch L; Friedl A; Schlegel M; Kuster SP; Kahlert CR; Kohler P;
PLoS Med; 2022 Nov; 19(11):e1004125. PubMed ID: 36342956
[TBL] [Abstract][Full Text] [Related]
7. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH
PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766
[TBL] [Abstract][Full Text] [Related]
8. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR
JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999
[TBL] [Abstract][Full Text] [Related]
9. Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.
Nielsen KF; Moustsen-Helms IR; Schelde AB; Gram MA; Emborg HD; Nielsen J; Hansen CH; Andersen MA; Meaidi M; Wohlfahrt J; Valentiner-Branth P
PLoS Med; 2022 Nov; 19(11):e1004037. PubMed ID: 36413551
[TBL] [Abstract][Full Text] [Related]
10. Estimated Protection of Prior SARS-CoV-2 Infection Against Reinfection With the Omicron Variant Among Messenger RNA-Vaccinated and Nonvaccinated Individuals in Quebec, Canada.
Carazo S; Skowronski DM; Brisson M; Sauvageau C; Brousseau N; Gilca R; Ouakki M; Barkati S; Fafard J; Talbot D; Gilca V; Deceuninck G; Garenc C; Carignan A; De Wals P; De Serres G
JAMA Netw Open; 2022 Oct; 5(10):e2236670. PubMed ID: 36239934
[TBL] [Abstract][Full Text] [Related]
11. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study.
Menni C; Valdes AM; Polidori L; Antonelli M; Penamakuri S; Nogal A; Louca P; May A; Figueiredo JC; Hu C; Molteni E; Canas L; Österdahl MF; Modat M; Sudre CH; Fox B; Hammers A; Wolf J; Capdevila J; Chan AT; David SP; Steves CJ; Ourselin S; Spector TD
Lancet; 2022 Apr; 399(10335):1618-1624. PubMed ID: 35397851
[TBL] [Abstract][Full Text] [Related]
12. Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study.
Bager P; Wohlfahrt J; Bhatt S; Stegger M; Legarth R; Møller CH; Skov RL; Valentiner-Branth P; Voldstedlund M; Fischer TK; Simonsen L; Kirkby NS; Thomsen MK; Spiess K; Marving E; Larsen NB; Lillebaek T; Ullum H; Mølbak K; Krause TG;
Lancet Infect Dis; 2022 Jul; 22(7):967-976. PubMed ID: 35468331
[TBL] [Abstract][Full Text] [Related]
13. Post-vaccination infection rates and modification of COVID-19 symptoms in vaccinated UK school-aged children and adolescents: A prospective longitudinal cohort study.
Molteni E; Canas LS; Kläser K; Deng J; Bhopal SS; Hughes RC; Chen L; Murray B; Kerfoot E; Antonelli M; Sudre CH; Pujol JC; Polidori L; May A; Hammers PA; Wolf J; Spector PTD; Steves CJ; Ourselin PS; Absoud M; Modat M; Duncan PEL
Lancet Reg Health Eur; 2022 Aug; 19():100429. PubMed ID: 35821715
[TBL] [Abstract][Full Text] [Related]
14. Likelihood of infecting or getting infected with COVID-19 as a function of vaccination status, as investigated with a stochastic model for Aotearoa New Zealand for Delta and Omicron variants.
Watson LM
N Z Med J; 2022 Apr; 135():89-100. PubMed ID: 35728188
[TBL] [Abstract][Full Text] [Related]
15. Favorable outcomes of COVID-19 in vaccinated hematopoietic stem cell transplant recipients: A single-center experience.
Tan JY; Wee LE; Tan YH; Conceicao EP; Lim FWI; Chen Y; Than H; Quek JKS; Nagarajan C; Goh YT; Hwang WYK; Phua GC; Chung SJ; Tan TT; Linn YC; Ho AYL; Tan BH
Transpl Infect Dis; 2023 Jun; 25(3):e14024. PubMed ID: 36715661
[TBL] [Abstract][Full Text] [Related]
16. Associations of COVID-19 symptoms with omicron subvariants BA.2 and BA.5, host status, and clinical outcomes in Japan: a registry-based observational study.
Nakakubo S; Kishida N; Okuda K; Kamada K; Iwama M; Suzuki M; Yokota I; Ito YM; Nasuhara Y; Boucher RC; Konno S
Lancet Infect Dis; 2023 Nov; 23(11):1244-1256. PubMed ID: 37399831
[TBL] [Abstract][Full Text] [Related]
17. Effect of Previous COVID-19 Vaccination on Humoral Immunity 3 Months after SARS-CoV-2 Omicron Infection and Booster Effect of a Fourth COVID-19 Vaccination 2 Months after SARS-CoV-2 Omicron Infection.
Kim J; Seo H; Kim HW; Kim D; Kwon HJ; Kim YK
Viruses; 2022 Nov; 14(11):. PubMed ID: 36366556
[TBL] [Abstract][Full Text] [Related]
18. Severe Fatigue and Persistent Symptoms at 3 Months Following Severe Acute Respiratory Syndrome Coronavirus 2 Infections During the Pre-Delta, Delta, and Omicron Time Periods: A Multicenter Prospective Cohort Study.
Gottlieb M; Wang RC; Yu H; Spatz ES; Montoy JCC; Rodriguez RM; Chang AM; Elmore JG; Hannikainen PA; Hill M; Huebinger RM; Idris AH; Lin Z; Koo K; McDonald S; O'Laughlin KN; Plumb ID; Santangelo M; Saydah S; Willis M; Wisk LE; Venkatesh A; Stephens KA; Weinstein RA;
Clin Infect Dis; 2023 Jun; 76(11):1930-1941. PubMed ID: 36705268
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for post-COVID-19 condition (Long Covid) in children: a prospective cohort study.
Morello R; Mariani F; Mastrantoni L; De Rose C; Zampino G; Munblit D; Sigfrid L; Valentini P; Buonsenso D
EClinicalMedicine; 2023 May; 59():101961. PubMed ID: 37073325
[TBL] [Abstract][Full Text] [Related]
20. Generation of neutralizing antibodies against Omicron, Gamma and Delta SARS-CoV-2 variants following CoronaVac vaccination.
Silva ARD; Villas-Boas LS; Tozetto-Mendoza TR; Honorato L; Paula A; Witkin SS; Mendes-Correa MC
Rev Inst Med Trop Sao Paulo; 2022; 64():e19. PubMed ID: 35239863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
